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Priming Task 
by 
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Supervisor: Michael Telch 
Recent animal and human research suggest that a behavioral prime before 
extinction training lessen the spontaneous recovery of learned fear.  These findings would 
have large ranging implications if they could be applied to the treatment of specific 
phobias in which spontaneous recovery is often problematic.  The present study 
examined the effects of a behavioral prime paired with exposure therapy versus exposure 
therapy alone on snake and spider phobics return of fear at one-month follow-up.   The 
findings did not support the proposed hypothesis that those in the primed group would 
show a significant lessening in return of fear.  The study findings do not support the 
current research, but there were a number of steps that may be taken in the future to gain 
more objective measurements. 
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Introduction 
Exaggerated or persistent fear is a common occurrence in psychiatric disorders.  
Anxiety disorders represent one of the most commonly diagnosed disorders, with a 31% 
lifetime prevalence (Kessler, et al., 1994).  The overall economic burden of anxiety 
disorders through both direct and indirect costs average approximately 42.3 billion 
dollars per year (Greenberg, et al., 1999).   Without treatment, these disorders tend to 
have a chronic course with a low rate of spontaneous remission.  Specific phobias 
represent one of the most commonly occurring disorders with a lifetime prevalence of 
about 11% (Kessler, et al. 1994).  These rates climb even higher when one considers 
subclinical presentations (Birchall, 1996).   Paradoxically, few patients present at anxiety 
clinics for specific phobia treatment as a primary diagnosis (Barlow, et al., 1986, Kessler, 
Zhao, et al., 1999 Antony, 2000).  These patients live with the disorder, despite the 
relatively short time investment it takes to treat it.  In the present study, we examine 
populations with significant arachnophobia or ophidiophobia.   
Arachnophobia and ophidiophobia both fall under the specific phobia umbrella of 
animal phobia, which is one of the most commonly occurring specific phobias (Curtis, et 
al., 1998). Animal phobias tend to have onset in childhood (Antony, et al 1997; Ost,1987; 
Marks & Gelder, 1966; Himle, et al., Craske, Burton, et al., 1989).  Women are also more 
likely to experience these fears than men (Fredrikson, et al., 1996). In addition or in lieu 
of fear, those with animal phobias, in particular snakes and spiders, may experience 
disgust specific to the stimulus as well.  (Thorpe & Salkovskis, 1998).  While fear is the 
primary construct of a phobia, disgust can be an important co-variable in treatment 
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outcome.   The accepted “gold standard”  method of treatment for animal phobias is 
exposure therapy. 
The efficacy of exposure-based treatments for specific phobias has been well 
established (Wolitzky-Taylor, Horowitz, Powers, & Telch, 2008).  However, studies on 
the long term maintenance of the gains of anxiety treatment are lacking. Rachman posits 
that a number of individuals experience return of fear after successful treatment due to 
“some form of disturbance, in consolidation, or dishabituation, or both” (1989).  Return 
of fear is the process by which an extinguished fear experiences spontaneous recovery in 
the time period between the end of evaluation and follow-up treatment.  This return of 
phobic behavior has been reported in multiple studies (Craske, 1999, Rachman 1989), 
including one in which 62% of responders showed a return of signs of clinically 
significant avoidance, and 45% showed a return of  clinically significant symptoms of 
their specific phobia (Lipsitz, et al., 1999).    Therefore, it is necessary to pioneer 
methods to reduce the return of fear after extinction.  This will help to increase the long-
term efficacy of specific phobia treatments and decrease the associated costs for follow-
up treatment to maintain treatment gains. 
Recent research in the field of memory has suggested a possible manipulation to 
reduce return of fear.  Reconsolidation is the process of once again consolidating 
memories after they have been actively recalled. After recall, memory must be 
reconsolidated or it will be forgotten.   Reconsolidation involves neural processes that are 
similar to those in consolidation.  During reconsolidation, the memory enters a labile 
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state in which changes to the already encoded memory are possible.  This period of 
instability is known to persist for several hours following memory retrieval. In contrast, 
fear extinction leads to the weakening of an emotional response, not by direct 
modification of the existing memory, but by formation of a new memory that suppresses 
activation of the initial memory.  The efficacy of this inhibition, however, is strongly 
contingent upon spatial, temporal, and sensory variables (Mineka, Mystkowski, Hladek, 
and Rodriguez, 1999).    
Previous work in animal models demonstrates that the administration of protein 
inhibitors successfully enables reconsolidation blockade.  However, utilizing this 
technique in human models presents a multitude of challenges.  Protein synthesis 
blockade requires direct administration of the inhibitors to the brain (Nader, 2003).  This 
is an invasive procedure and unethical to conduct in humans.  Additionally, application of 
protein synthesis inhibitors is imprecise because current methodologies lack the ability to 
chemically target human memories without causing damage to structures within the 
brain.  However, recent work suggests that use of a behavioral priming technique may be 
an efficacious alternative for re-encoding previously consolidated memories (Monfils, et 
al, 2008; Schiller, et al. 2008). 
In preliminary trials, fear-trained rat and human participants were primed with an 
isolated retrieval trial of their feared stimulus.  After a critical time period had passed, 
researchers administered extinction training. Both rats and humans that experienced this 
fear prime followed by a delay before extinction training exhibited reduced fear 
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expression and a significant reduction in return of fear at follow-up (Monfils et al., 2008; 
Schiller et al., 2008).  This critical time period is known as the lability window and 
remains open between ten minutes and six hours after the original memory’s priming 
(Nader, Schafe, & LeDoux, 2000) 
.   The current study hopes to devise an effective, drug-free paradigm for the 
reduction of return of fear.  It capitalizes on the mechanistic differences between 
reconsolidation and extinction, thus not only providing extinction training, but also 
manipulating the previously consolidated memory while it is in a labile post-retrieval 
state.   
The aim is to test this parameter in phobics, and to determine if this manipulation 
may be able to persistently attenuate their fear to a specific animal stimulus using a subtle 
modification to standard exposure therapy treatment.  Participants are given a single, 
isolated exposure trial prior to the standard repeated exposure session to capitalize on the 
critical time period of the memory’s labile state.   
In the context of specific phobias, the fear-inducing stimulus (e.g., a spider or 
snake) has not necessarily ever been “paired” with an unconditioned stimulus, yet it 
engages brain mechanisms that overlap with those engaged during fear conditioning.  The 
rationale in the present study is that exposure to a single fear inducing stimulus engages a 
number of molecular cascades (e.g., noradrenergic signaling, glutamatergic transmission) 
which may facilitate the updating of the individuals’ interpretation of the memory 
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associated with the stimulus.  At the same time, the previously encoded interpretation 
associated with this stimulus becomes labile and thus amenable to re-interpretation.   
The exposure technique will utilize massed exposure (ME) for the extinction trial.  
ME is simple to implement with the population.  Additionally, there is evidence that 
those receiving expanding spaced exposure (ESE) exhibit less return of fear (Rowe & 
Craske, 1998).  Since the current study examines mechanistic changes, it is crucial that 
no parts of the exposure itself are primarily responsible for reduction in return of fear.  
Viewing reconsolidation purely without the confound of ESE would be essential to 
determining the efficacy of the priming variable. 
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Methods 
Participants 
Fifty-four students were recruited to participate in the study.  Of this, thirty-two 
participants were eligible for enrollment in the study’s treatment phase.  Participants were 
recruited primarily from the Introduction to Psychology Subject Pool at the University of 
Texas at Austin, and through advertisements posted at various locations throughout 
campus.  In addition, some participants referred new participants by word of mouth.  To 
be eligible for the screening, participants had to a) be at least 18 years of age; b) not 
currently taking a psychoactive medication; c) have not previously received exposure 
treatment for their phobia, and d) have reported a score of 54 or higher on the FSQ.  To 
be eligible for the treatment phase of the study, participants had to score a 50 or higher on 
both behavioral approach tests (BAT).   Eligible participants ranged in age from 18-40.  
Of the thirty-two participants, 28 were female, and only 4 were male.  Additionally, 
46.8% were Caucasian, 9.3% African American, 21.8% Asian American, and 18.7% 
Hispanic American.  One participant declined to identify their race.   
Animals 
Animals used in the exposure were a live American corn snake (species: Elaphe 
guttata guttata; body length approximately 122 cm; body width approximately 7.6 cm), 
African ball python (species: python regius; body length approximately 85 cm; body 
width approximately 12 cm), and two live Chilean Rose tarantulas (species: Grammostola 
Rosea; body length approximately 4 cm; body width approximately 2.5 cm).  None of the 
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species are poisonous or venomous.  Animals were cared for according to the regulations 
by the IACUC for animal care at the University of Texas Austin.   
The American corn snake, “Bob,” always functioned as the training animal for 
snake phobia treatment.  The ball python, “Spot,” was always used as the generalization 
animal for snake phobia treatment.  The Chilean rose tarantula, “Brad,” who has darker 
coloring, was always used as the training animal for the spider phobia treatment.  The 
Chilean rose tarantula, “Tobey,” who has lighter pinker coloring, was always used as the 
generalization animal for the spider phobia treatment. 
 
Measures 
Self Report Measures 
Demographics:  Each participant filled out a standard demographics form that 
asked for their age, gender, marital status, ethnicity, and years of education.   
Armfield and Mattiske’s Disgust Scale (Armfield and Mattiske, 1996): This test 
presents 8 statements about the disgust-provoking aspects of spiders and spider behavior. 
The subject rates each statement on a scale from 0 (strong disagreement) to 6 (strong 
agreement). Scores range from 0 to 48, with higher scores indicating a greater feeling of 
disgust towards spiders.  This scale was also adapted to assess disgust towards snakes. 
Spider Belief Questionnaire (SBQ): The SBQ (Arntz, Lavy, Van den Berg, & Van 
Rijsoort, 1993) measures the strength of various beliefs related to spiders. Subjects rate 
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their belief in 42 spider-related statements dealing with qualities such as unpredictability 
and potential to cause harm. They also rate 36 statements about their own predicted 
behavior, involving responses such as panic and paralysis. All ratings are on a scale from 
0% (no belief at all) to 100% (complete belief). The total scores range from 0 to 100, 
with higher scores indicating a greater fear of spiders and of one’s responses to spiders.  
This scale was also adapted to assess the fear of snakes. 
Fear of Spider Questionnaire (FSQ): The FSQ (Szymanski & O’Donohue, 1995) 
focuses on current thoughts and reactions to spiders. Questions include "currently, I 
sometimes think about getting bit by a spider" and "I would feel very nervous if I saw a 
spider now." Subjects rate 18 statements about spider fear on a scale from 0 (strongly 
disagree) to 6 (strongly agree). The total score ranges from 0 to 108, with higher scores 
indicating a greater fear of spiders.  This scale was also adapted to assess the fear of 
snakes. 
Spider Phobia Questionnaire (SPQ): The SPQ (Watts & Sharrock, 1984) probes 
subjects' reactions to spider fear on a number of subscales: vigilance, preoccupation, 
avoidance-coping, and cognitive-behavioral. Questions include "do you make very sure 
there are no spiders around before taking a bath" (vigilance) and "are you sometimes 
distracted by thoughts about spiders" (preoccupation). Subjects answer 32 questions with 
“yes” or “no,” earning one point for each “yes” response. Scores range from 0 to 32, with 
higher scores indicating a greater fear of spiders.  This scale was also adapted to assess 
the fear of snakes. 
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The Comprehensive International Diagnostic Interview (CIDI), Version 1.0. 
(World Health Organization, 1990) was used to assess the psychological status of 
potential participants. The CIDI is a multi-module, computer-based instrument used to 
assist in diagnosing psychological and psychiatric disorders.  In this study, only the 
phobia module was utilized, as it would have been too time-consuming to administer the 
full CIDI.  
The Behavioral Approach Test (BAT) tests the subjective fear and disgust 
experienced by each participant to their feared stimulus. Before the approach, 
participants rate their expected fear and expected disgust level on a 0-100 scale.   Each 
participant is asked to get within a 1 foot block of their feared stimulus and remain there 
for two minutes.  Participants then rate their peak fear and peak disgust on a 0-100 scale.  
Participants who are unable to begin the BAT are automatically given a rating of 100 for 
peak fear.    
Procedure 
Data collection began in spring 2009 and continued through summer 2010.  Pre-
screening for potential participants occurred through the University of Texas at Austin’s 
OPERA system.  This large subject pool completed both the Fear of Spider and Fear of 
Snake Questionnaires.  Eligible participants were contacted via e-mail with screening 
questions regarding their current psychoactive drug use and previous phobia treatment.  
Researchers invited eligible responders to the Phase I screening process (n=54).   
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During Phase I, all participants completed self-report measures.  Each of these 
participants completed two BATs, one with the generalization stimulus and one with the 
training stimulus.  Those who were deemed eligible based on two BAT scores of 50 or 
higher, were invited to Phase II of the study. 
Phase II of the study included randomization, treatment, a one-day post, and a 
one-month follow-up.   Participants were randomized to either a priming condition with 
exposure treatment or exposure treatment only.  All participants received six three-
minute exposure sessions with the training stimulus as part of their treatment in which 
they must remain within a one foot block of the stimulus animal’s head.  If the animal 
moved, the participant was required to move accordingly in order to maintain a constant 
one foot block distance.  The exposure treatment was self-guided; participants were 
permitted to move closer the stimulus if they desired.   Those randomized to pre-
treatment priming received a ten second prime with the stimulus followed by a thirty 
minute wait, in which they answered unrelated psychological questions on the CIDI to 
serve as a uniform method of waiting.  Those who were randomized to exposure only 
received an additional 10 seconds at the end of their treatment in order to receive equal 
exposure time.  During the one-day post, participants again performed two BATs, one 
with the training stimulus and one with the generalization stimulus.  Lastly, at the one-
month follow-up, subjects again completed all screening forms and completed two 
BATs. 
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Results 
Fifty-four students participated in Phase I of the study.  Of these, thirty-two 
completed Phase II of the study.  The demographic characteristics are presented in Table 
1. Only four participants were men.
Independent sample t-tests revealed that there were no significant pre-treatment 
differences between the primed and exposure only groups in their reported levels of fear 
and disgust on all self-report measures and pre-treatment BATs.  Treatment in both 
groups significantly lowered fear at one-day post, but this was expected, as exposure is 
an efficacious treatment for specific phobia (see Table 2).  At one month follow-up, fear 
continued to decline and was significantly lower than at post across all groups (see Table 
3).   Contrary to what was initially hypothesized, at the one-month follow-up, there failed 
to be any significant differences in return of fear between groups. 
ANOVA’s were performed on the main outcomes of interests.  The generalization 
stimulus mean peak fear was lower for the primed group, but not at a rate approaching 
significance (F(1, 27)= 1.954, p=.174, exposure only mean = 25.14, primed mean = 
14.43).  The training stimulus mean peak fear was lower for the primed group as well, 
but again not at a rate approaching significance (F (1,27)=1.074, p=.310 exposure only 
mean = 17.57, primed mean =  11.07.  The study as it stands proves the null hypothesis.  
There was no difference between the primed and exposure only groups.  This went 
against the prediction that the primed group would contribute to a significant alleviation 
of their fear at the one month follow-up.  Both groups continued to maintain the gains 
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they had achieved through their short exposure interventions, and in fact continued to 
gain on the progress they had made at their one day post assessment (See Fig 1 and Fig 
2). 
No significant co-variants were found when controlling for phobia type, gender, 
or level of pre-treatment fear and disgust.  
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Discussion 
The hypothesis that all participants would show a significant decrease in fear due 
to exposure therapy was supported.  Exposure itself was highly effective in treating the 
phobias as expected.   Participants showed highly significant (p<.01) reductions of fear at 
a one-day post and one-month follow-up with only eighteen minutes and ten seconds of 
total exposure time.  Additionally, participants showed this large reduction in fear with 
both the generalization and training stimulus, regardless of animal fear type.  Many 
participants spontaneously reported how happy they were about participating in the study 
and that they thought they had received lasting gains by participating.   
 However, the main hypothesis that the priming group would show significantly 
less return of fear than the exposure only group did not find support in the present study.  
This was unexpected given the strong indications from previous animal and human 
studies.   
While the results of this pilot were not significant, it should be noted that the 
general fear patterns were in line with what was predicted from previous animal and 
human models of reconsolidation.  Interestingly, the primed subjects exhibited a drop in 
fear at follow-up for both the training and generalization, so it is possible with the 
addition of more subjects, this finding may eventually become significant.  Power 
analysis showed that 40-50 subjects would be ideal for such an analysis (See Figure 3).  
The addition of these 8-18 subjects may be enough to push these findings into 
significance or trends.  Further research will be conducted that adjusts several variables, 
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including an increased number of participants, in order to meet the power analysis’ 
projections. 
Consistent with previous research, the majority of our eligible participants were 
women.  Additionally no potential participants were excluded on the basis of having 
received previous treatment for a phobia.  No effects on disgust as a treatment outcome 
or as co-variable for fear level were found. 
Limitations 
As previously stated, the power analysis (see Figure 3) indicates that the current 
study needs more participants in order to give an accurate test for significance.  The 
recruitment of a larger number of subjects who are willing to participate in a study with 
their fear stimulus would be a good starting point.  Thirteen otherwise eligible subjects 
from Phase I refused treatment citing their fear as a main point for not participating (See 
Figure 4).  It is possible that the selection of subjects thus self-selected towards those 
who were eager and willing to get treatment and also towards those who exhibited a 
subjectively lower level of fear than those who refused.   
The study used a non-clinical sample from the University of Texas at Austin.  
While the participants reported a significant fear of snakes and spiders in order to be 
included in the study, it is probable that they did not truly have a phobia as defined by the 
DSM-IV-TR.  Therefore, it is possible that a floor effect on treatment occurred.  
Participants gained so much from the treatment there was not a high return of fear at the 
one month follow-up.  It is possible using a more severe population we would reduce the 
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floor effect, and see a significant difference between the priming group and the exposure 
only group. 
Additionally, each participant got a significant amount of exposure time, totaling 
eighteen minutes.  Less exposure time may lessen the floor effects that treatment seemed 
to provide, as there is little return of fear across both groups.  Future research may 
involve shortening exposure times in order to tease out the possible effect of priming.  
Exposure therapy for phobias is one of the most efficacious treatments in the field of 
psychology (Wolitzky, Horowitz, Powers, & Telch, 2008).  In this study, the exposure 
therapy may have been too effective in treatment, thus resulting in complications with 
respect to analyzing the experimental effect. 
It has been discussed that the BATs were perhaps too long and thus had an 
unintentional therapeutic effect.  It is possible that the length of the BATs allowed the 
subjects to begin experiencing habituation.    Shortening the BATs to thirty seconds from 
two minutes would help reduce this problem.  Future iterations of this study will shorten 
the BAT so as not to provide for the beginnings of habituation.  The animals used in the 
study were incredibly docile and nine Phase I participants did not qualify for Phase II 
based solely on the fact their reported fear was not high enough in these initial BATs (see 
Figure 4). 
The study only measured subjective ratings of fear.  Future revisions of this study 
will aim to use objective measurements, such as skin conductance readings to gain 
additional insight into the biological indications of a fear response.  Galvanic skin 
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responses can be measured with relative precision.  The galvanic skin response measures 
heightened emotions such as fear or sexual arousal (Dawson and Schell, 1990).  Skin 
conductance readings can be gathered with relative ease and pose no risk to participants.  
The readings are analyzed via a computer program, thus reducing the additional costs and 
expenses of laboratory processing that other objective biological measures such as 
salivary cortisol samples would pose..   
Lastly, follow-up took place only after one month due to the mobile nature of the 
selected population.  It is possible that testing after a longer time span may reveal 
significant results.  Human studies have previously shown a significant difference 
between primed and non-primed groups at a one year mark (Schiller et al, in press).  
Delaying follow-up to a later point in time may result in a larger differentiation between 
groups.   
Implications for future research and intervention 
The findings of the present study do not support the idea of priming as a valid 
method for reducing return of fear in simple animal phobias.  It is possible phobia 
memories are too complex to be recalled in a single isolated retrieval.  Previous human 
and animal research looked at only simple trained fears.  However, this area of research 
should continue to be explored.  Previous animal and human research both indicate that 
this method may still yield effective treatment options and provide further insight into the 
mechanistic workings of anxiety disorders.  Simple and effective strategies that can 
augment current exposure techniques would be a valuable tool for any clinician in 
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practice.  Since specific phobias have a high rate of reoccurrence, it is important to 
develop clinically valid tools that can help further treat anxiety disorders.  Adjusting 
some of the variables from this pilot will help determine if the priming technique can be 
used for the larger and more nebulous specific phobias versus learned and distinct fears. 
Furthermore, this research aims to examine the mechanisms of reconsolidation.  
Priming represents a promising way of understanding how the memory narrative can 
change and distort during the lability period.   Developing and understanding these 
priming techniques would provide substantial insight into the process of reconsolidation, 
as well as the ability to manipulate previous memories.  Combining these 
neuropsychological findings with clinically applicable treatments represents an important 
partnership across psychological domains that will allow for reconsolidation to be more 
fully understood. 
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Figures 
Figure 1 
Effects of the Priming Task- Training Context 
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Figure 2 
Effects of the Priming Task- Generalization Context
Figure 3 Power Analysis
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Figure 4 -Consort Guidelines 
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Tables 
Table 1 
Demographics 
Ethnicity Percentage of Participants 
Caucasian 46.80% 
African 
American 9.30% 
Asian American 21.80% 
Hispanic 18.70% 
Refused 3.40% 
100.00% 
Table 2 
One sample t-tests 
Group Significance Pre fear mean 
Post fear 
mean 
Exposure only -generalization p< .00 82.706 28.625 
Exposure only -training p< .00 82.06 21.125 
Primed group-generalization p< .00 83 29.071 
Primed group-training p< .00 76.333 18.786 
Table 3 
One sample t-tests 
Group Significance 
Post fear 
mean 
Follow-up 
mean 
Exposure only -generalization p<.00 28.625 25.143 
Exposure only-training p<.01 21.125 17.571 
Primed group-generalization p<.01 29.071 14.429 
Primed group-training p<.03 18.786 11.071 
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